Vitamin D deficiency and the COVID-19 pandemic
Author(s) -
Patrick Zemb,
Peter Bergman,
Carlos A. Camargo,
Étienne Cavalier,
Catherine Cormier,
Marie Courbebaisse,
Bruce W. Hollis,
Fabrice Joulia,
Salvatore Minisola,
Stefan Pilz,
Paweł Płudowski,
François Schmitt,
Mihnea Zdrenghea,
Jean-Claude Souberbielle
Publication year - 2020
Publication title -
journal of global antimicrobial resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.917
H-Index - 26
eISSN - 2213-7173
pISSN - 2213-7165
DOI - 10.1016/j.jgar.2020.05.006
Subject(s) - covid-19 , vitamin d deficiency , medicine , pandemic , vitamin d and neurology , vitamin , randomized controlled trial , virology , outbreak , disease , infectious disease (medical specialty)
Highlights • Vitamin D deficiency is very common.• Randomised controlled trials showed that vitamin D decreases acute respiratory infections (ARIs).• Vitamin D deficiency is an easily modifiable factor of ARIs.• Daily vitamin D supplementation with moderate doses is safe and cheap.• Even a small decrease in COVID-19 infections would easily justify this intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom